Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.160
+0.030 (2.65%)
At close: Jul 3, 2025, 1:00 PM
1.168
+0.008 (0.70%)
After-hours: Jul 3, 2025, 3:57 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $70.27 million as of July 3, 2025. Its market cap has decreased by -55.70% in one year.
Market Cap
70.27M
Enterprise Value
-97.90M
1-Year Change
-55.70%
Ranking
Category
Stock Price
$1.16
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $70.27M, a decrease of -88.64%. That is a compound annual growth rate of -41.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 68.45M | -33.76% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 694.61B |
| Johnson & Johnson | 373.88B |
| AbbVie | 338.11B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 286.11B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 234.20B |
| AstraZeneca | 221.11B |